API
< Back to situations

[ORGANIZATION]

Scanntech

Featured in 6 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

343 clusters · 1318 sources · last updated

Latest: FDA issues warning for GLP-1 drugs over vision loss risks

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, neurodegenerative, heart, sleep apnea, and addiction healt

[QUIET] [HEALTH] [BR]

Brazil plans semaglutide integration into SUS

12 clusters · 172 sources · last updated

Latest: Anvisa regulates weight-loss medications and seizes irregular supplements

The Brazilian Ministry of Health is progressing with plans to incorporate semaglutide-based weight-loss medications into the Unified Health System (SUS). On September 24, 2026, the Ministry submitted a formal request to

Also covered in